Volume 4 Supplement 2
Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Meeting abstracts
Publication of this supplement was made possible with support from the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health.
11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research. Go to conference site.
Bethesda, MD, USA6-7 October 2008
Page 1 of 2
-
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P1
-
Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O1 -
AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P2 -
Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O2 -
Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P3 -
Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O3 -
Malignancies in HIV infected children at a tertiary cancer hospital in India
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P4 -
A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O4 -
Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P5 -
AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O5 -
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P6 -
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O6 -
Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P7 -
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O7 -
Therapeutic options in AIDS related Kaposi's sarcoma: a 5-year Nigerian review
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P8 -
High resolution profiling of DNA copy number and gene expression changes in AIDS-related lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O8 -
Dendritic cell-mediated infection of primary B cells with KSHV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P9 -
Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O9 -
Survival and prognosis of HIV-associated non-Hodgkin-lymophma in the era of combined anti-retroviral therapy, a European multi-cohort study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P10 -
Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O10 -
A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P11 -
HIV induces the expression of activation-induced cytidine deaminase (AICDA) in B cells through a direct interaction between virion-associated CD40L and CD40
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O11 -
Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P12 -
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O12 -
Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P13 -
An invasion mechanism for human papillomavirus related cancers: HPV 16 E6 degrades PTPN13 allowing enhanced map kinase signaling
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O13 -
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P14 -
Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O14 -
Marijuana use and cervical HPV/neoplasia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P15 -
Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O15 -
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P16 -
Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O16 -
Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P17 -
Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O17 -
Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P18 -
Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O18 -
The role of the TRAF2/3 binding site in LMP1 and CD40 signaling
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P19 -
Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O19 -
KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P20 -
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O20 -
Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P21 -
Implementation of a "see and treat" cervical cancer prevention program linked to HIV care in Zambia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O21 -
Burkitt lymphoma in Brazil is characterized by geographically distinct clinico-pathological features and lack of p53 mutations
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P22 -
Trends in cancer incidence among HIV-infected persons in California, 1996–2006
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O22 -
Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P23 -
Profiling viral and host microRNA expression in cells infected with KSHV and EBV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O23 -
Tobacco, alcohol and use of other recreational drugs within HIV-infected treated cohorts: the IeDEA West Africa collaboration
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P24 -
Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O24 -
Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P25 -
Risk of death among Italian AIDS cases with AIDS-defining cancers in the post-HAART era
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O25
-
Affiliated with
-
Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Citation Impact
3.698 - 2-year Impact Factor (2021)
3.572 - 5-year Impact Factor (2021)
1.03 - Source Normalized Impact per Paper (SNIP)
0.774 - SCImago Journal Rank (SJR)Speed
29 days to first decision for all manuscripts (Median)
54 days to first decision for reviewed manuscripts only (Median)Usage
493,723 Downloads (2022)
350 Altmetric mentions (2021)
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.